On January 30, 2024, Matthew Sykes, an analyst at Goldman Sachs, continued to express his bullish sentiment on Guardant Health...

On January 30, 2024, Matthew Sykes, an analyst at Goldman Sachs, expressed his optimistic stance on the stock of Myriad...

On January 30, 2024, Polaris Inc (PII) unveiled their Q4 financial results, which were met with a mixed response from...

Celestica's stock has experienced a significant surge in value following the release of their impressive Q4 financial results and optimistic...

On January 30, 2024, MaxCyte and Wugen forged an innovative alliance through the signing of a strategic platform license (SPL)...

On January 30, 2024, United Parcel Service Inc. (UPS) announced its financial results for the fourth quarter of fiscal 2023....

On January 30, 2024, Raymond James analyst Srini Pajjuri made a significant downgrade to AMD shares, shifting their rating from...

On January 30, 2024, Pfizer delivered a surprising fourth-quarter profit, defying expectations despite a decline in COVID product sales. The...

On January 30, 2024, Truist Securities analyst Michael Ciarmoli expressed his opinion on Woodward (NASDAQ:WWD), maintaining a Hold rating while...

On January 30, 2024, MSCI shares experienced a surge in trading activity as the company unveiled its impressive financial results...